Sofie Priem

Sofie Priem has extensive work experience in the field of nonclinical safety and toxicology. Sofie started their career at Innogenetics as a Senior Researcher and worked there from 1998 to 2007. Sofie then joined Ablynx, where they held various positions including Associate Scientist Bioanalytics, Scientist Pharmacology-Bioanalysis, Senior scientist Pharmacology/ Study monitor toxicology, and Senior Scientist - Study monitor Toxicology. At Ablynx, Sofie was responsible for evaluating the toxicology of lead Nanobodies, coordinating and overseeing projects at CROs, and ensuring compliance with regulatory guidelines. In 2019, they joined arGEN-X as a Senior Scientist Nonclinical Safety and later became a Principal Scientist Nonclinical Safety.

Sofie Priem completed their Master's degree in Biomedical Sciences at the Vrije Universiteit Brussel from 1992 to 1996. Sofie then pursued a Bachelor's Degree in Specifieke Lerarenopleiding at IVO from 2015 to 2017. Prior to these degrees, Sofie attended Hemelsdaele from 1985 to 1991, although the specific degree and field of study are unknown. In 2021, they obtained certification as a European Registered Toxicologist from the European Register of Toxicologists.